Literature DB >> 28456936

Combination of High-Sensitivity C-Reactive Protein and Homocysteine Predicts the Post-Stroke Depression in Patients with Ischemic Stroke.

Li-Shan Cheng1, Wen-Jun Tu2, Yuan Shen3, Li-Jun Zhang3, Kangxiang Ji3.   

Abstract

In this study, we examined the changes in high-sensitivity C-reactive protein (Hs-CRP) and homocysteine (HCY) levels, two of the risk factors, during the acute period of ischemic stroke (IS) and evaluated the relationship between these two factors and long-term post-stroke depression (PSD). In this study, 259 patients with IS had finished the follow-up and were included. Based on the symptoms, diagnoses of depression were made in accordance with DSM-IV criteria for depression at 1 year after stroke. The influence of Hs-CRP/CHY levels on PSD was performed by binary logistic regression analysis and receiver operating characteristic curves (ROC). Totally, 94 out of the 259 patients were diagnosed as PSD (36.3%; 95% CI 30.4-42.1%). In multivariate logistic regression analysis, the third and fourth quartiles of Hs-CRP or HCY were significantly associated with PSD during the observation period compared to the first quartile group (P < 0.05). In addition, patients with depression were older and more frequently were female, living with offspring, widowhood, higher initial stroke severity, and BMI. HCY improved the ability of Hs-CRP [0.72 (95% CI 0.66-0.79)] to diagnose PSD (AUC of the combined model 0.76; 95% CI 0.69-0.82; P = 0.021). The patient group with higher levels of both Hs-CRP and HCY (> median) had an OR of 6.05 (95 % CI 3.13-10.15; P < 0.001) for PSD compared with patients with lower levels of both factors (< median). The data suggests that elevated serum levels of Hs-CRP and HCY were associated with the risk of developing PSD 1 year after the stroke onset, and those two factors combined to add prognostic information in the early evaluation of PSD.

Entities:  

Keywords:  C-reactive protein; Depression; Homocysteine; Ischemic stroke

Mesh:

Substances:

Year:  2017        PMID: 28456936     DOI: 10.1007/s12035-017-0549-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  29 in total

Review 1.  Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.

Authors:  Heath D Schmidt; Richard C Shelton; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

2.  The relationship between high-sensitivity C-reactive protein at admission and post stroke depression: a 6-month follow-up study.

Authors:  Rui-Rui Yang; Bo-Cheng Lu; Tao Li; Yi-Feng Du; Xiang Wang; Yan-Xia Jia
Journal:  Int J Geriatr Psychiatry       Date:  2015-06-04       Impact factor: 3.485

3.  Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke.

Authors:  J W Eikelboom; G J Hankey; S S Anand; E Lofthouse; N Staples; R I Baker
Journal:  Stroke       Date:  2000-05       Impact factor: 7.914

4.  The association between C-reactive protein levels and depression: Results from the northern Finland 1966 birth cohort study.

Authors:  Timo Liukkonen; Sylvi Silvennoinen-Kassinen; Jari Jokelainen; Pirkko Räsänen; Maija Leinonen; V Benno Meyer-Rochow; Markku Timonen
Journal:  Biol Psychiatry       Date:  2006-04-17       Impact factor: 13.382

Review 5.  Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.

Authors:  M Bryant Howren; Donald M Lamkin; Jerry Suls
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

6.  Association of serum homocysteine with major depressive disorder: results from a large population-based study.

Authors:  Hermann Nabi; Murielle Bochud; Jennifer Glaus; Aurélie M Lasserre; Gérard Waeber; Peter Vollenweider; Martin Preisig
Journal:  Psychoneuroendocrinology       Date:  2013-05-23       Impact factor: 4.905

Review 7.  Poststroke depression: prevalence, diagnosis, treatment, and disease progression.

Authors:  Robert G Robinson
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

8.  Association of plasma homocysteine concentration with atherosclerotic carotid plaques and lacunar infarction.

Authors:  Tsutomu Sasaki; Manabu Watanabe; Yoji Nagai; Taku Hoshi; Masashi Takasawa; Masaru Nukata; Akihiko Taguchi; Kazuo Kitagawa; Naokazu Kinoshita; Masayasu Matsumoto
Journal:  Stroke       Date:  2002-06       Impact factor: 7.914

9.  Plasma levels of glutamate during stroke is associated with development of post-stroke depression.

Authors:  Sai-Yu Cheng; Yan-Dong Zhao; Jie Li; Xiao-Yan Chen; Ruo-Dan Wang; Jun-Wei Zeng
Journal:  Psychoneuroendocrinology       Date:  2014-05-17       Impact factor: 4.905

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  19 in total

Review 1.  Association between homocysteine levels in acute stroke and poststroke depression: A systematic review and meta-analysis.

Authors:  Yupei Chen; Hua Zou; Meidi Peng; Yan Chen
Journal:  Brain Behav       Date:  2022-05-23       Impact factor: 3.405

Review 2.  The advances of post-stroke depression: 2021 update.

Authors:  Jianglong Guo; Jinjing Wang; Wen Sun; Xinfeng Liu
Journal:  J Neurol       Date:  2021-05-30       Impact factor: 4.849

Review 3.  Risk Factors for Post-stroke Depression: A Meta-analysis.

Authors:  Yu Shi; Dongdong Yang; Yanyan Zeng; Wen Wu
Journal:  Front Aging Neurosci       Date:  2017-07-11       Impact factor: 5.750

4.  Plasma homocysteine concentrations and risk of intracerebral hemorrhage: a systematic review and meta-analysis.

Authors:  Zhike Zhou; Yifan Liang; Huiling Qu; Mei Zhao; Feng Guo; Chuansheng Zhao; Weiyu Teng
Journal:  Sci Rep       Date:  2018-02-07       Impact factor: 4.379

5.  Impact of homocysteine levels on clinical outcome in patients with acute ischemic stroke receiving intravenous thrombolysis therapy.

Authors:  Lei Li; Xiaoye Ma; Li Zeng; Sajan Pandey; Ronghao Wan; Rui Shen; Quanbin Zhang
Journal:  PeerJ       Date:  2020-07-10       Impact factor: 2.984

6.  C-reactive protein and post-stroke depressive symptoms.

Authors:  Katarzyna Kowalska; Paulina Pasinska; Elzbieta Klimiec-Moskal; Joanna Pera; Agnieszka Slowik; Aleksandra Klimkowicz-Mrowiec; Tomasz Dziedzic
Journal:  Sci Rep       Date:  2020-01-29       Impact factor: 4.379

7.  Cerebral Small Vessel Disease Burden Is Associated With Poststroke Depressive Symptoms: A 15-Month Prospective Study.

Authors:  Yan Liang; Yang-Kun Chen; Vincent Chung-Tong Mok; De-Feng Wang; Gabor S Ungvari; Winnie Chiu-Wing Chu; Hee-Ju Kang; Wai-Kwong Tang
Journal:  Front Aging Neurosci       Date:  2018-02-28       Impact factor: 5.750

8.  Decreased level of irisin, a skeletal muscle cell-derived myokine, is associated with post-stroke depression in the ischemic stroke population.

Authors:  Wen-Jun Tu; Han-Cheng Qiu; Qiang Liu; Xuemei Li; Ji-Zong Zhao; Xianwei Zeng
Journal:  J Neuroinflammation       Date:  2018-05-02       Impact factor: 8.322

9.  Relationship Between Serum Fibrinogen Level and Depressive Symptoms in an Adult Population with Spinal Cord Injury: A Cross-Sectional Study.

Authors:  Zhiping Xie; Chengcai Li; Zelong Xing; Wu Zhou; Shenke Xie; MeiHua Li; Yujuan Zhou
Journal:  Neuropsychiatr Dis Treat       Date:  2021-07-06       Impact factor: 2.570

10.  The Prognostic Determinant of Interleukin-10 in Patients with Acute Ischemic Stroke: An Analysis from the Perspective of Disease Management.

Authors:  Wen Sun; Shuhui Wang; Shanji Nan
Journal:  Dis Markers       Date:  2021-07-17       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.